BRASILI, Livio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.082
EU - Europa 6.891
AS - Asia 2.233
SA - Sud America 48
AF - Africa 18
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 8
Totale 21.292
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.997
GB - Regno Unito 2.313
SE - Svezia 1.212
IT - Italia 1.141
CN - Cina 751
SG - Singapore 640
DE - Germania 625
UA - Ucraina 407
HK - Hong Kong 333
FI - Finlandia 249
TR - Turchia 220
FR - Francia 191
BG - Bulgaria 176
BE - Belgio 143
RU - Federazione Russa 118
IN - India 115
IE - Irlanda 83
NL - Olanda 79
CA - Canada 71
RO - Romania 51
IR - Iran 36
BR - Brasile 33
ID - Indonesia 32
LT - Lituania 32
JP - Giappone 17
PL - Polonia 17
IL - Israele 16
PK - Pakistan 13
CH - Svizzera 12
OM - Oman 10
VN - Vietnam 9
AU - Australia 8
CL - Cile 8
EU - Europa 8
CI - Costa d'Avorio 7
CZ - Repubblica Ceca 7
ES - Italia 7
KR - Corea 6
MX - Messico 6
PT - Portogallo 6
TW - Taiwan 5
BY - Bielorussia 4
LU - Lussemburgo 4
MY - Malesia 4
NZ - Nuova Zelanda 4
AE - Emirati Arabi Uniti 3
BZ - Belize 3
CO - Colombia 3
EE - Estonia 3
EG - Egitto 3
IQ - Iraq 3
TH - Thailandia 3
UG - Uganda 3
AM - Armenia 2
AR - Argentina 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NG - Nigeria 2
NO - Norvegia 2
PR - Porto Rico 2
SA - Arabia Saudita 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AO - Angola 1
AT - Austria 1
BD - Bangladesh 1
BH - Bahrain 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GR - Grecia 1
HU - Ungheria 1
IS - Islanda 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
ME - Montenegro 1
MM - Myanmar 1
NP - Nepal 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VE - Venezuela 1
YE - Yemen 1
Totale 21.292
Salva come PNG Salva come JPEG
Città #
Southend 1.851
Santa Clara 1.333
Fairfield 1.108
Woodbridge 992
Chandler 913
Jacksonville 870
Houston 822
Ann Arbor 784
Ashburn 610
Nyköping 555
Dearborn 553
Singapore 484
Seattle 453
Wilmington 413
Cambridge 353
Hong Kong 310
Modena 247
Beijing 214
Sofia 175
New York 167
Eugene 165
Princeton 161
Brussels 143
San Diego 141
Izmir 134
Des Moines 123
Helsinki 118
Dublin 80
Amsterdam 63
Munich 61
Chicago 54
Fremont 52
Milan 50
Redwood City 50
London 43
Moscow 43
Shanghai 42
Norwalk 41
Bremen 40
Toronto 36
Boardman 35
Falls Church 33
Philadelphia 32
Shenzhen 30
Bologna 29
Kunming 29
Hefei 28
West Jordan 28
Rome 27
Guangzhou 25
Horia 24
Augusta 23
Verona 23
Grafing 21
Leawood 21
Jakarta 20
Los Angeles 19
Nanjing 19
San Mateo 17
Bengaluru 15
Frankfurt am Main 15
Parma 15
Saint Petersburg 15
San Francisco 15
Ottawa 14
Auburn Hills 13
Jerusalem 13
Jinan 12
Paris 12
Umeå 12
Zanjan 12
Chiswick 11
Hounslow 11
Indiana 11
Kilburn 11
Pasadena 11
San Jose 11
Brooklyn 10
Padova 10
Romainville 10
Tulsa 10
Wuhan 10
Mcallen 9
Nanchang 9
Nuremberg 9
Timisoara 9
Warsaw 9
Bandung 8
Florence 8
Fuzhou 8
Las Vegas 8
Montréal 8
Naples 8
Old Bridge 8
Palermo 8
Pavia 8
Turin 8
Abidjan 7
Albuquerque 7
Andover 7
Totale 15.755
Salva come PNG Salva come JPEG
Nome #
(2,2-difenil-[1,3]-diossolan-4ilmetil)-(3-fenil-propil)-ammina: nuovo agonista parziale del recettore serotoninergico 5-HT1A 520
1,3-Dioxane as a scaffold for potent and selective 5-HT1AR agonist with in-vivo anxiolytic, anti-depressant and anti-nociceptive activity 401
1,2,4-Benzothiadiazine derivatives as alpha(1) and 5-HT1A receptor ligands 355
1,3-Dioxolane-Based Ligands as a Novel Class of Alpha1-Adrenoceptor Antagonists 352
1 '-Benzyl-3,4-dihydrospiro[2H-1-benzothiopyran-2,4 '-piperidine] (Spipethiane), a potent and highly selective sigma(1) ligand 331
1,3-Dioxolane-Based Ligands as Rigid Analogues ofNaftopidil: Structure–Affinity/Activity Relationships at a1and 5-HT1A Receptors 311
1,3-Diossolani e analoghi aperti come nuovi ligandi per il recettore Sigma 308
1,4-Dioxolane-triazaspirodecanone derivatives as nociceptin/orphanin FQ receptor ligands 308
1,3-Dioxolane-Based Ligands Incorporating a Lactam or Imide moiety: Structure-Affinity/Activity Relationship at alpha1–Adrenoceptor subtypes and at 5-HT1A Receptors 303
1,3-dioxolane-based ligands in the search for alpha1-adrenergic antagonists. 293
Synthesis, biological evaluation and molecular modeling of 1-oxa-4-thiaspiro- and 1,4-dithiaspiro[4.5]decane derivatives as potent and selective 5-HT1A receptor agonists 247
A New and Versatile Synthesis of 1,3-Dioxan-5-yl-pyrimidine and Purine Nucleoside Analogues 244
5-Arylbenzothiadiazine Type Compounds as Positive Allosteric Modulators of AMPA/Kainate Receptors 241
Structure-Activity Relationship within a new series of σ1 and σ2 receptor ligands: identification of a novel σ2R agonist (BS148) with selective toxicity against metastatic melanoma 234
Synthesis of Heteroaryl ortho-Phenoxyethylamines via Suzuki Cross-Coupling: Easy Access to New Potential Scaffolds in Medicinal Chemistry 233
Scouting new sigma receptor ligands: Synthesis, pharmacological evaluation and molecular modeling of 1,3-dioxolane-based structures and derivatives 220
Discovery Of New Sigma-2 Receptor Agonist Endowed With Antiproliferative Activity 217
Evaluation of stereo and chemical stability of chiral compounds 216
Efficient synthesis of 5,6-dihydro-8H-[1,2,4]thiadiazino[6,5,4-de] phenanthridine 4,4-dioxide and 5,6-dihydro-8H-[1,2,4]-thiadiazino[6,5,4-ij] thieno[2,3-c]quinoline 4,4-dioxide 216
Synthesis, structural characterization and biological evaluation of 4′-C-methyl- and phenyl-dioxolane pyrimidine and purine nucleosides 211
1-(1,4-Dioxa-spiro[4.5]dec-2ylmethyl)-4-(2-methoxy-phenyl)-piperazine: SAR at alpha1 and 5-HT1A Receptors. 207
Diastereoselective Synthesis of (1,3-Dioxan-4-yl)pyrimidine and Purin Nucleoside Analogues 204
Exhaustive CoMFA and CoMSIA analyses around different chemical entities: A ligand-based study exploring the affinity and selectivity profiles of 5-HT1A ligands 202
Enantiomeric resolution of [(2,2-diphenyl-1,3-dioxolan-4-yl)methyl](2-phenoxyethyl)amine, a potent α1and 5-HT1Areceptor ligand: an in vitro and computational study 200
Discovery of a new series of 5-HT1A receptor agonists 196
Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at α1 and 5-HT1A receptors 195
Development, Validation and Application of an LC-MS/MS Bioanalytical Method for the Quantification of GF449, A Novel 5-HT1A Agonist, in Rat Plasma and Brain. 195
(2,2-Diphenyl-[1,3]oxathiolan-5-ylmethyl)-(3-phenylpropyl)-amine: a Potent and Selective 5-HT1A Receptor Agonist 194
A homology modelling-driven study leading to the discovery of the first mouse trace amine-associated receptor 5 (TAAR5) antagonists 194
Transacetalization of Acetals with Butane-1,2,4-triol Using Cobalt(II) Chloride and Chlorotrimethylsilane 192
Synthesis and Structure-Activity Relationships of Triazaspirodecanone Derivatives as Nociceptin/Orphanin FQ Receptor Ligands 191
Synthesis of 5-Methyl-1,3-oxathiolane-based Nucleoside Analogues as Potential Antiviral Agents 190
Synthesis and Antimuscarinic Activity of Some Ether- and Thioether-Bearing 1,3-dioxolanes and Related Sulfoxides and Sulfones 187
2-(2-phenylcyclopropyl) imidazolines: Reversed enantioselective interaction at I-1 and I-2 imidazoline receptors 186
Investigation of the effect of different linker chemotypes on the inhibition of histone deacetylases (HDACs) 186
Synthesis and antimuscarinic activity of some N-(4-dimethylaminomethyl-2-phenyl-1,3)dioxolan-2-ylmethyl)lactam methiodides 178
Synthesis, enantiomeric separation and docking studies of spiropiperidine analogues as ligands of the nociceptin/orphanin FQ receptor 175
Further insights into the pharmacology of the human Trace Amine-Associated Receptors: discovery of novel ligands for TAAR1 by a virtual screening approach 169
Insights into the structure of the Human TAAR5 receptor: a computational study 169
CONFORMATIONAL AND CONFIGURATIONAL STUDY OF 1,3-DIOXOLANES BY PROTON AND CARBON NMR-SPECTROSCOPY 169
Synthesis, absolute configuration and antimuscarinic activity of the enantiomers of [1-(2,2-diphenyl-[1,3]dioxolan-4-yl)-ethyl]dimethyl-amine 166
Discovery of a new 5-HT1A receptor agonist, acting ‘in vivo’ in a rat model of anxiety and depression 164
Synthesis, biological evaluation and molecular modelling of 1-oxa-4-thiaspiro- and 1,4-dithiaspiro[4.5]decane derivatives as potent and selective 5-HT1A receptor agonists 163
Pyrrolidine Derivatives as New Ligands for 5-HT1A Receptors 163
Affinity and efficacy correlate with chemical structuremore than potency does in a series of pentatomic cyclicmuscarinic agonists 161
2-D and 3-D modeling of imidazoline receptor ligands: Insights into pharmacophore 159
Synthesis and antimuscarinic activity of derivatives of 2-substituted-1,3-dioxolanes 155
An unexpected central hypertensive effect of the new imidazoline compound benazoline 151
Insights into the structure and pharmacology of the human trace amine-associated receptor 1 (hTAAR1): homology modelling and docking studies 151
Scouting Sigma Receptor Ligands As New Tools For The Treatment Of Neurodegenerative Diseases And Cancer 151
Second Joint Italian-Swiss Meeting on Medicinal Chemistry , Italy, Modena 19-20 February 2005. 151
Synthesis and pharmacological evaluation of 1-benzylpiperazine and 4-benzylpiperidine as potent sigma ligands. 148
Identification of a Potent and Selective 5-HT1AReceptor Agonist with In Vitro and In Vivo Antinociceptive Activity 147
Alpha-Adrenoceptor occupancy by N,N-dimethyl-2-bromo-2-phenethylamine hydrobromide (DMPEA) in rat vas deferens 145
Derivati 1,3-diossanici come ligandi alpha1 adrenergici e 5-HT1A serotoninergici. 144
The XIXth National Meeting on Medicinal Chemistry: Verona, Italy 144
Synthesis and biological evaluations of 4-alkyl-1-Arylpiperazine derivatives: SAR at 5-HT1A and 1 –Adrenoreceptor 142
I-1 imidazoline receptor-mediated effects on apoptotic processes in PC12 cells 141
Structure Activity Relationships at 5-HT1A receptors within a novel series of 4-alkyl-1-arylpiperazine derivatives 141
Novel Dithiolane-Based Ligands Combining Sigma and NMDA Receptor Interactions as Potential Neuroprotective Agents 141
Benzothiadiazine derivatives as 1 and 5-HT1A receptor ligands. 140
Synthesis and structure-activity relationships of 1-aralkyl-4- benzylpiperidine and 1-aralkyl-4-benzylpiperazine derivatives as potent σ ligands 137
Synthesis, Biological Evaluation and Docking Studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at Adrenergic alpha1- and Serotonine 5-HT1A receptors 135
Synthesis, structural characterization and pharmacological evaluation of spiroxatrine analogs as potential nociceptin/orphanin FQ receptor ligands 135
Synthesis and biological evaluation of 1,3-dioxolane-based 5-HT 1A receptor agonists for CNS disorders and neuropathic pain 135
Ligand binding to I-2 imidazoline receptor: The role of lipophilicity in quantitative structure-activity relationship models 134
Synthesis and Pharmacological Evaluation of Some Analogues of the Ca-Antagonist Cinnarizine 133
Synthesis, NMR spectroscopy study, and antimuscarinic activity of a series of 2-(acyloxymethyl)-1,3-dioxolanes 132
Insights into the structure and pharmacology of Trace Amine-Associated Receptor 1 (TAAR1), a new target for medicinal chemistry 132
Synthesis and structure-activity relationship studies in a series of 2-substituted 1,3-dioxolanes modified at the cationic head 128
Synthesis, Pharmacological Evaluation and Selectivity Profile of Isomeric 2-Phenyl-2-cyclohexyl-4-[(dimethylamino)methyl]-1,3-dithiolane Methiodide as Potent Antimuscarinic Agents 127
Fluoronorepinephrines: further pharmacological evaluation in vitro and in pithed rats 127
A Novel Class of 1,3-Oxathiolane Nuclosides Analogues Having Potent Anti-HIV Activity. 126
Imidazoline receptors: Qualitative structure-activity relationships and discovery of tracizoline and benazoline. Two ligands with high affinity and unprecedented selectivity 125
Synthesis and Anti-HIV Activity of 1,3-Dithiolane Nucleosides 120
Heteroarylphenoxyethyl amine as selective 5-HT1A receptor ligands: synthesis and structure-activity ralationship studies. 120
Pharmacological Characterization of Chiral Muscarinic Antagonists cis-2-Phenyl-2-cyclohexyl-r-5-[(dimethylamino)-methyl]1,3-oxathiolane-3-oxide Methiodide 120
Ring opening effect at alpha1-adrenoceptor subtypes and 5-HT1A receptors within a novel class of 1,3-Dioxolane-based ligands 119
Coupling of I-1 imidazoline receptors to the cAMP pathway: Studies with a highly selective ligand, benazoline 119
Effect of aromatic substitution on antimuscarinic activity of 2-phenyl-2-cyclohexyl-4-[(dimethylamino)methyl]-1,3-dioxolanes 117
Fallot's tetralogy and squatting position 115
Pyrimidinyl or Purinyl 1,3-Dioxolanes and 1,3-Dithiolanes, Methods for their Preparation and Their Use as Virucides 114
Synthesis and pharmacological evaluation of Spiroxatrine derivatives as potential ligands for NOP receptor 114
Structure_Activity Relationships among Methoctramine-Related Polymethylene Tetramine. Chain Length and Substituent Effects on M2 Muscarinic Receptor Blocking Activity. 113
2-{[(2-(2,6-Dimethoxyphenoxy)ethyl]}-1,4-benzoxathiano:A New Antagonist With High Potency and Selectivity Toward alpha1-Adrenoreceptors. 113
Alpha2-Adrenoceptors Profile Modulation anf High Antinociceptove Activity of (S)-)2-[1-(Biphenyl-2-yloxy)ethyl]-4,5-dihydro-1H-imidazole 112
Nuova Serie di Ligandi Sigma a Struttura Piperazinica e Piperidinica 112
Structure Activity Relationship at 5-HT1A receptors within a novel series of spiro-1,3-Dioxolane-based ligands 111
Structure-activity relationship at alpha-adrenergic receptors within a series of imidazoline analogues of cirazoline 111
Resolution of the potent α1-adrenoreceptor antagonist 2-[[[2-(2,6-dimethoxyphenoxy)ethyl]amino]methyl]-1,4-benzoxathian (benoxathian) 110
Structure-Activity Relationships in Prazosin-Related Compounds. Effect of Replacing a Piuperazine Ring with an Alkanediamine Moiety on alpa1-Adrenoreceptor Blocking Activity. 108
Investigation within a new series of heterocyclic biaryl piperazines acting at 5-HT1A serotoninergic receptors 108
Pharmacological Characterizazion of Muscarinic Receptor Subtypes in Rabbit Isolated Tissue Preparation 107
Derivati 1,3-Diossanici come Antagonisti Muscarinici 107
Risoluzione della miscela racemica del (±)-(2,2-difenil-[1,3]diossolan-4-ilmetil)-(2-fenossi-etil) ammina, potente antagonista alpha1 adrenergico, 107
Synthesis and structural characterization of spiroxatrine derivatives as potential non-peptide ligands for NOP receptor 106
Effect of the rigidification of propranolol, a mixed β-adrenoceptor and 5-HT1AR antagonist 106
Determination of Muscarinic Agonist Potencies at M1 and M2 Muscarinic Receptors in a Modified Pithed Rat 105
Structure-Activity Relationships at alpha1-Adrenoceptor Subtypes within a New Series of 1,3-Dioxolane Derivatives 104
MOLECULAR PROPERTIES OF THE ADRENERGIC a-RECEPTORIII - Origin of topographicol duqlism in the reaction of a receptor thiolwith symmetrical and unsymmetrical polyamine disulfides. 103
Totale 17.315
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.101
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.101
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.280 0 0 0 0 0 493 595 303 345 107 228 209
2020/20213.052 335 122 227 282 322 195 315 321 203 382 220 128
2021/20222.709 116 304 180 291 123 172 92 155 343 203 401 329
2022/20233.074 524 329 180 299 316 464 88 238 378 69 127 62
2023/20241.859 57 108 163 162 465 176 128 241 35 88 91 145
2024/20252.532 288 81 113 404 1.108 538 0 0 0 0 0 0
Totale 21.515